Solasia Pharma KK's total assets for Q2 2026 were ¥1.90B, a decrease of -4.77% from the previous quarter. DE:9SO total liabilities were ¥443.00M for the fiscal quarter, a 57.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.